T. Rowe Price Associates
GOSS icon

T. Rowe Price Associates’s Gossamer Bio GOSS Stock Holding History

T. Rowe Price Associates’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-132,026
Closed -$44K – 3282
2026
Q1 		$44K Buy
132,026
+18,888
+17% +$29.7K ﹤0.01% 3077
2025
Q4 		$351K Buy
113,138
+12,480
+12% +$35.6K ﹤0.01% 2563
2025
Q3 		$265K Buy
100,658
+5,367
+6% +$11.8K ﹤0.01% 2662
2025
Q2 		$118K Buy
95,291
+30,514
+47% +$33.3K ﹤0.01% 2861
2025
Q1 		$72K Hold
64,777
– – ﹤0.01% 2879
2024
Q4 		$59K Sell
64,777
-6,369,269
-99% -$5.46M ﹤0.01% 2910
2024
Q3 		$6.35M Buy
6,434,046
+939,252
+17% +$904K ﹤0.01% 1233
2024
Q2 		$4.95M Buy
5,494,794
+2,603,789
+90% +$1.95M ﹤0.01% 1229
2024
Q1 		$3.41M Sell
2,891,005
-804,222
-22% -$885K ﹤0.01% 1340
2023
Q4 		$3.37M Buy
+3,695,227
New +$2.73M ﹤0.01% 1330
2023
Q3 		– Sell
-1,318,680
Closed -$1.58M – 2899
2023
Q2 		$1.58M Buy
1,318,680
+244,150
+23% +$304K ﹤0.01% 1574
2023
Q1 		$1.35M Sell
1,074,530
-234,277
-18% -$448K ﹤0.01% 1635
2022
Q4 		$2.84M Buy
1,308,807
+1,298,783
+12,957% +$10.7M ﹤0.01% 1347
2022
Q3 		$121K Buy
+10,024
New +$124K ﹤0.01% 2686

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

T. Rowe Price Associates's GOSS Position: Q2 2026 in Review

T. Rowe Price Associates sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 132,026 shares — an estimated $44K sold.

T. Rowe Price Associates first reported a position in GOSS in Q3 2022 and held it in 14 quarters. The position peaked at $6.35M in Q3 2024. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • T. Rowe Price Associates reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 132,026 Gossamer Bio shares in Q2 2026, an estimated $44K.
  • T. Rowe Price Associates first reported a position in Gossamer Bio in Q3 2022 and held it in 14 quarters.
  • T. Rowe Price Associates's Gossamer Bio position peaked at $6.35M in Q3 2024.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.